Mixed trend on the daily chart: above its 50- and 200-day averages · 50-day below the 200-day · SuperTrend down since Nov 21 · inside the Ichimoku cloud · RSI 0 (oversold) · MACD above its signal · at its 52-week high
None of the 29 investors followed here reported a position in ISCNF in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a ISCNF trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0% | ||
| 2025 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0% |
| 2024 | -16.7 | 0.0 | -98.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -90.0 | 0.0 | −99.8% |
| 2023 | 28.0 | 5.5 | -17.8 | 1.8 | 123.5 | -20.8 | 15.0 | 0.0 | -34.1 | -20.5 | -8.7 | -45.5 | −40.0% |
| 2022 | 124.1 | 12.0 | -13.1 | -20.2 | 1.3 | -10.5 | -16.8 | -8.6 | -20.8 | -4.9 | -48.1 | -33.3 | −68.8% |
| 2021 | 35.0 | 7.6 | -9.4 | -6.8 | -23.7 | 4.3 | -34.4 | -37.3 | -0.7 | -5.8 | -15.5 | -49.5 | −84.0% |
| 2020 | -30.6 | -26.6 | 13.4 | -36.1 | 113.3 | 9.3 | -24.8 | -15.3 | -16.4 | 3.0 | 29.4 | -9.1 | −44.4% |
| 2019 | 0.0 | -15.8 | 12.5 | 22.2 | -9.1 | -1.0 | -19.2 | -37.5 | 0.0 | 67.0 | 14.2 | 25.8 | +26.3% |
| 2018 | -11.9 | -9.2 | -18.6 | -12.3 | -55.8 | -23.1 | -11.8 | -10.0 | -18.3 | -13.9 | 0.0 | 0.0 | −89.1% |
| 2017 | — |
No insider transactions reported for ISCNF.
No analyst coverage for this instrument.
Isracann Biosciences Inc., together with its subsidiaries, cultivates and distributes medical cannabis in Israel. The company also develops cultivation facilities. It exports its products to Germany. The company was formerly known as Atlas Blockchain Group Inc. and changed its name to Isracann Biosciences Inc. in October 2019. Isracann Biosciences Inc. was founded in 2010 and is headquartered in Vancouver, Canada.
No recent headlines.